To investigate long-term retinal changes after microincision pars plana vitrectomy surgery (MIVS) for macular hole (MH) in retinitis pigmentosa (RP) patients—retrospective and observational study.

Please provide your email address to receive an email when new articles are posted on . Previous unsuccessful topical therapy does not affect outcomes in patients who undergo surgical macular hole ...

Facedown positioning following surgery is not more likely to close large (≥400 mcm) macular holes compared with seating faced forward, according to a study published in JAMA Ophthalmology. However, ...

Transplanted human stem cells successfully repaired macular holes in monkey models of the disorder. This is according to a new study from researchers at the Center for Biosystems Dynamics Research at ...

Among retina surgeons, there is an ongoing debate around the value and necessity of face-down positioning after macular hole surgery. Historically, patients with macular hole surgery would be ...

Medicated drops may help close small macular holes over a two- to eight-week period, allowing some people to avoid surgery to fix the vision problem, a new study suggests. The findings, based on a ...

Germany's IQWiG Confirms That ThromboGenics' JETREA® Demonstrates Major Added Value for the Treatment of Vitreomacular Traction and Macular Hole ThromboGenics NV (Euronext Brussels: THR) a ...

In this Healio Video Perspective, Dilraj Grewal, MD, discusses a presentation from the Retina Society meeting exploring the efficacy of autologous retinal transplant for the treatment of refractory ...

Medicated drops may help close small macular holes over a two- to eight-week period, allowing some people to avoid surgery to fix the vision problem, a new study suggests. The findings, based on a ...

Japanese researchers have successfully used a transplant of human stem cells to close a hole in a key part of a monkey's retina. They say the achievement could pave the way for better treatment of ...

WAUSAU, Wis. (WSAW) - Geographic atrophy affects approximately one million people in the United States and is commonly associated with both dry and wet macular degeneration. Now a new treatment is ...